Clinical trial

Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals

NCT06427421

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention Frequency of Treg and Teffs Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Phenotype of Treg and Teffs Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention RNA seq analysis Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention HLA typing Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention beta-cell autoantibody dosage Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Glycated haemoglobin (HbA1C) dosage Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention blood glucose dosage Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention C-peptide dosage Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-05-06

PhaseNA

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

Frequency of Treg and TeffsBIOLOGICAL

Phenotype of Treg and TeffsBIOLOGICAL

RNA seq analysisBIOLOGICAL

HLA typingBIOLOGICAL

beta-cell autoantibody dosageBIOLOGICAL

Glycated haemoglobin (HbA1C) dosageBIOLOGICAL

blood glucose dosageBIOLOGICAL

C-peptide dosageBIOLOGICAL

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

URC-CIC Paris Descartes Necker Cochincollaborator

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06427421 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.